At a glance
ClinicalIndex Comparison RecordN/ACompleted· 269 enrolled
Drug / intervention
Medical Marijuanadrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Medical Marijuana on Neurocognition and Escalation of Use
In Brief
A clinical study evaluating Medical Marijuana for Pain and 3 related conditions. Completed, enrolled 269 participants across 1 site.
Detailed Summary
This study will use a randomized controlled design to test whether patients who use medical marijuana, compared to a waitlist control group, experience a change in health outcomes (relief of symptoms, or adverse health outcomes such as new-onset symptoms of cannabis use disorders, neurocognitive impairments) or brain-based changes.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Insomnia, Depression, Anxiety
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartJul 2017
First PostedJul 2017
Primary CompletionFeb 2021
Study CompletionNov 2022
TodayJul 2026
First PostedJul 21, 2017
Enrollment StartJul 1, 2017
Primary CompletionFeb 5, 2021
Study CompletionNov 1, 2022
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 8.9 years ago
Interventions
Medical Marijuanadrug
Patients in this group can choose when, where, and how much medical marijuana to use.